We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

EU Pricing & Reimbursement Newsletter

27 November 2014

Welcome to this special edition of the Hogan Lovells EU Pricing & Reimbursement newsletter.

This newsletter provides comprehensive overviews of the system of pricing and reimbursement of medicinal products and medical devices in EU member states Belgium, the Czech Republic, France, Germany, Italy, the Netherlands, Spain, and the UK as well as in Russia. The EU member states covered by this newsletter account for approximately three quarters of the EU 28 pharmaceutical market value and a similar proportion of market value for medical devices.

Each country chapter provides a summary of the pricing and reimbursement system, an overview of legislation and key players, and describes how the pricing and reimbursement systems work in each such country. We hope that you will find this special edition of our Pricing & Reimbursement newsletter practical and interesting.

Hogan Lovells’ European Commercial & Regulatory team is part of our Global Life Sciences practice, with more than 350 dedicated and experienced life sciences lawyers and specialists worldwide.

Read more: Hogan Lovells EU Pricing & Reimbursement newsletter.

The team

Loading data